BridgeBio Pharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2017
Period Ending	Nov '25 Nov 28, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2017
Market Capitalization	10,925	12,554	5,009	6,354	1,066	2,159	Upgrade
Market Cap Growth	63.32%	150.63%	-21.16%	496.14%	-50.63%	-69.70%	Upgrade
Enterprise Value	12,033	13,597	6,434	7,444	2,125	2,870	Upgrade
Last Close Price	62.18	62.18	27.01	38.91	10.92	12.70	Upgrade
PS Ratio	25.55	29.36	23.37	754.92	14.67	35.22	Upgrade
PB Ratio	-6.18	-7.10	-3.56	-5.23	-0.91	-2.84	Upgrade
EV/Sales Ratio	27.80	31.80	30.02	884.51	29.25	46.81	Upgrade
Debt / Equity Ratio	-0.90	-0.90	-1.19	-1.30	-1.38	-1.99	Upgrade
Net Debt / Equity Ratio	-0.61	-0.61	-0.72	-0.97	-1.00	-1.03	Upgrade
Net Debt / EBITDA Ratio	-2.57	-2.57	-1.84	-2.20	-2.71	-1.57	Upgrade
Net Debt / FCF Ratio	-2.85	-2.85	-2.01	-2.47	-2.95	-1.74	Upgrade
Asset Turnover	0.54	0.54	0.30	0.02	0.10	0.08	Upgrade
Quick Ratio	2.52	2.52	4.44	3.04	4.03	6.34	Upgrade
Current Ratio	2.77	2.77	4.67	3.32	4.52	6.58	Upgrade
Return on Assets (ROA)	-33.83%	-33.83%	-49.24%	-64.08%	-35.80%	-41.75%	Upgrade
Return on Capital Employed (ROCE)	-77.50%	-77.50%	-75.50%	-148.90%	-93.40%	-65.30%	Upgrade
Earnings Yield	-5.65%	-4.92%	-10.33%	-9.16%	-42.24%	-22.91%	Upgrade
FCF Yield	-3.48%	-3.03%	-10.06%	-7.53%	-37.25%	-20.82%	Upgrade
Buyback Yield / Dilution	-2.93%	-2.93%	-14.30%	-10.39%	-2.16%	-22.34%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.